For McDSL, WHO grade ranked the first, followed by molecular genetic group and histologic type or tumor location; for LASSO, WHO grade ranked the first, followed by IDH mutation, and molecular group or 1p/19q codeletion; for Cox analysis, the WHO grade ranked the first, followed by radiotherapy and histologic type. This evidence concerns the gene IDH2 and neoplasm.